Mylan Gets PTAB To Invalidate Sanofi Injector Patent
The Patent Trial and Appeal Board has invalidated a Sanofi-Aventis injector pen patent in a challenge from Mylan, saying it was obvious in light of two earlier patents and a patent...To view the full article, register now.
Already a subscriber? Click here to view full article